Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fufeng Wang

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
International Immunopharmacology|August 16, 2024
Comprehensive genomic and spatial immune infiltration analysis of survival outliers in extensive-stage small cell lung cancer receiving first-line chemoimmunotherapyYuxin Jiang, Jingyuan Xie, Qinpei Cheng, et al.
International Journal of Surgery (London, England)|May 14, 2024
Molecular characteristics of early-onset compared with late-onset colorectal cancer: a case controlled studyJunwei Tang, Wen Peng, Chuanxing Tian, et al.
Frontiers in Oncology|September 25, 2023
Case Report: Cancer spectrum and genetic characteristics of a <i>de novo</i> germline <i>POLD1</i> p.L606M variant-induced polyposis syndromeYing Zhang, Xiaolu Wang, Yuning Zhu, et al.
Frontiers in Oncology|July 10, 2023
Immune microenvironment analysis and novel biomarkers of early-stage lung adenocarcinoma evolutionJun Liu, Yaxin Ji, Xiaodan Weng, et al.
Frontiers in Oncology|February 9, 2026
Personalized tumor-informed circulating tumor DNA monitoring for early detection of recurrence in postoperative pancreatic cancerJingjing Chen, Lu Zou, Xinyuan Bai, et al.
BMC Cancer|January 27, 2026
Correction to: Recurrence risk prediction in resected stage I-III melanoma utilizing circulating tumor DNAMengke Zhao, Lianjun Zhao, Yueling Yang, et al.
BMC Cancer|November 25, 2025
Recurrence risk prediction in resected stage I-III melanoma utilizing circulating tumor DNAMengke Zhao, Lianjun Zhao, Yueling Yang, et al.
Cell Communication and Signaling : CCS|November 29, 2025
DECIPHER-PRAD: an advanced fragmentomics-based cell-free DNA assay for prostate cancer early detectionShun Zhang, Guanchen Zhu, Linfeng Xu, et al.
Clinical and Translational Medicine|June 9, 2020
Combinatorial assessment of ctDNA release and mutational burden predicts anti-PD(L)1 therapy outcome in nonsmall-cell lung cancerWenfeng Fang, Yuxiang Ma, Jiani C Yin, et al.
Breast Cancer Research : BCR|May 1, 2025
Unraveling breast cancer response to neoadjuvant chemotherapy through integrated genomic, transcriptomic, and circulating tumor DNA analysisMenghao Dong, Jian Chen, Nannan Lu, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
International Immunopharmacology|August 16, 2024
Comprehensive genomic and spatial immune infiltration analysis of survival outliers in extensive-stage small cell lung cancer receiving first-line chemoimmunotherapyYuxin Jiang, Jingyuan Xie, Qinpei Cheng, et al.
International Journal of Surgery (London, England)|May 14, 2024
Molecular characteristics of early-onset compared with late-onset colorectal cancer: a case controlled studyJunwei Tang, Wen Peng, Chuanxing Tian, et al.
Frontiers in Oncology|September 25, 2023
Case Report: Cancer spectrum and genetic characteristics of a <i>de novo</i> germline <i>POLD1</i> p.L606M variant-induced polyposis syndromeYing Zhang, Xiaolu Wang, Yuning Zhu, et al.
Frontiers in Oncology|July 10, 2023
Immune microenvironment analysis and novel biomarkers of early-stage lung adenocarcinoma evolutionJun Liu, Yaxin Ji, Xiaodan Weng, et al.
Frontiers in Oncology|February 9, 2026
Personalized tumor-informed circulating tumor DNA monitoring for early detection of recurrence in postoperative pancreatic cancerJingjing Chen, Lu Zou, Xinyuan Bai, et al.
BMC Cancer|January 27, 2026
Correction to: Recurrence risk prediction in resected stage I-III melanoma utilizing circulating tumor DNAMengke Zhao, Lianjun Zhao, Yueling Yang, et al.
BMC Cancer|November 25, 2025
Recurrence risk prediction in resected stage I-III melanoma utilizing circulating tumor DNAMengke Zhao, Lianjun Zhao, Yueling Yang, et al.
Cell Communication and Signaling : CCS|November 29, 2025
DECIPHER-PRAD: an advanced fragmentomics-based cell-free DNA assay for prostate cancer early detectionShun Zhang, Guanchen Zhu, Linfeng Xu, et al.
Clinical and Translational Medicine|June 9, 2020
Combinatorial assessment of ctDNA release and mutational burden predicts anti-PD(L)1 therapy outcome in nonsmall-cell lung cancerWenfeng Fang, Yuxiang Ma, Jiani C Yin, et al.
Breast Cancer Research : BCR|May 1, 2025
Unraveling breast cancer response to neoadjuvant chemotherapy through integrated genomic, transcriptomic, and circulating tumor DNA analysisMenghao Dong, Jian Chen, Nannan Lu, et al.
Pageof 4